StockData
ELI LILLY & Co logo

ELI LILLY & Co (LLY) operating KPIs

LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1417.54+43.84 (+3.19%)

Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%

Eli Lilly interest expense ($M) ($M)

Annual figures from Eli Lilly's filings and investor materials

Latest, FY2025
895
Period ended Dec 31, 2025
Change on a year earlier
+14.6%
781 in FY2024
History
18 years
Since FY2008
Sources
13
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedInterest expense ($M) ($M)Year on yearSource
FY2025Dec 31, 2025895+14.6%Form 10-K (filed 2026-02-12) ↗
FY2024Dec 31, 2024781+60.7%Form 10-K (filed 2026-02-12) ↗
FY2023Dec 31, 2023486+46.6%Form 10-K (filed 2026-02-12) ↗
FY2022Dec 31, 2022332-2.4%Form 10-K (filed 2023-02-22) ↗
FY2021Dec 31, 2021340-5.5%Form 10-K (filed 2022-02-23) ↗
FY2020Dec 31, 2020360-10.2%Form 10-K (filed 2021-02-17) ↗
FY2019Dec 31, 2019401+65.2%Form 10-K (filed 2020-02-19) ↗
FY2018Dec 31, 2018243+7.8%Form 10-K (filed 2020-02-19) ↗
FY2017Dec 31, 2017225+21.5%Form 10-K (filed 2018-02-20) ↗
FY2016Dec 31, 2016185+14.9%Form 10-K (filed 2017-02-21) ↗
FY2015Dec 31, 2015161+8.3%Form 10-K (filed 2016-02-19) ↗
FY2014Dec 31, 2014149-7.1%Form 10-K (filed 2015-02-19) ↗
FY2013Dec 31, 2013160-10.0%Form 10-K (filed 2014-02-19) ↗
FY2012Dec 31, 2012178-4.4%Form 10-K (filed 2013-02-21) ↗
FY2011Dec 31, 2011186+0.3%Form 10-K (filed 2012-02-24) ↗
FY2010Dec 31, 2010186-29.0%Form 10-K (filed 2012-02-24) ↗

Cite this data

StockData. (2026). Eli Lilly Interest expense ($M) ($M), annual FY2008–FY2025 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/fin_int_exp

See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.